Ledger.Open graph →
SEC Form D · filed May 10, 2021

CeleCor Therapeutics, Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Peter B. Finn · Boston, MAExec · DirectorAndreas B. Ritzi · Del Mar, CADirectorMatthew Kennedy · New York, NYExecRobert S. Hillman · San Diego, CAExec · DirectorSusan Webb · New York, NYExec · DirectorAndreas B. Ritzi · Del Mar, CADirectorBenjamin Fogle · West Des Moines, IADirectorPaul J. Newfield · Wellington, Q2DirectorJack B. Lief · Del Mar, CADirectorSteven W. Davis · Birmingham, ALExecPeter B. Finn · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗